Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis
Authors
Keywords
-
Journal
CANCER
Volume 122, Issue 7, Pages 1085-1096
Publisher
Wiley
Online
2016-02-01
DOI
10.1002/cncr.29892
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Asymptomatic Metastatic Castration-Resistant Prostate Cancer
- (2017) Cynthia L. Gong et al. Journal of the National Comprehensive Cancer Network
- Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis
- (2015) Louise Perrault et al. CUAJ-Canadian Urological Association Journal
- Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
- (2014) Alice Dragomir et al. BMC HEALTH SERVICES RESEARCH
- The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
- (2014) Florian Koerber et al. BMC HEALTH SERVICES RESEARCH
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events
- (2014) M.D. Krahn et al. Current Oncology
- Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada
- (2014) Reka Pataky et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model
- (2014) Chiranjeev Sanyal et al. PLoS One
- Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer
- (2013) Julia H. Hayes et al. ANNALS OF INTERNAL MEDICINE
- Atrial Fibrillation and Congestive Heart Failure: A Cost Analysis of Rhythm-Control vs Rate-Control Strategies
- (2013) Frédéric Poulin et al. CANADIAN JOURNAL OF CARDIOLOGY
- CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC): 2013 Update
- (2013) Fred Saad et al. CUAJ-Canadian Urological Association Journal
- Comparative Cost-effectiveness of Robot-assisted and Standard Laparoscopic Prostatectomy as Alternatives to Open Radical Prostatectomy for Treatment of Men with Localised Prostate Cancer: A Health Technology Assessment from the Perspective of the UK National Health Service
- (2013) Andrew Close et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer
- (2013) Przemysław Holko et al. Expert Review of Anticancer Therapy
- Health Care Costs for State Transition Models in Prostate Cancer
- (2013) Murray D. Krahn et al. MEDICAL DECISION MAKING
- Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis
- (2012) Matthew R. Cooperberg et al. BJU INTERNATIONAL
- Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer
- (2012) Rupesh Kotecha et al. Brachytherapy
- Cost-effectiveness of Intensity-modulated Radiotherapy in Prostate Cancer
- (2012) J.H.E. Yong et al. CLINICAL ONCOLOGY
- State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
- (2012) Uwe Siebert et al. VALUE IN HEALTH
- Lifetime economic burden of prostate cancer
- (2011) Michael E Stokes et al. BMC HEALTH SERVICES RESEARCH
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Active surveillance for prostate cancer compared with immediate treatment
- (2011) Kirk A. Keegan et al. CANCER
- Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer
- (2011) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy
- (2011) S. Iannazzo et al. VALUE IN HEALTH
- Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer
- (2010) Julia H. Hayes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population
- (2010) B. Alemayehu et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness analysis of immediate radical cystectomy versus intravesicalBacillusCalmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer
- (2009) Girish S. Kulkarni et al. CANCER
- Evaluation of direct medical costs of hospitalization for febrile neutropenia
- (2009) Nina Lathia et al. CANCER
- Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
- (2009) Ayal A. Aizer et al. RADIOTHERAPY AND ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More